RESUMO

Equine influenza is a highly contagious viral disease, specially among 1-5 years old naive horses. Vaccination is considered the best way to control the disease spread and outbreaks. Although foals are the main animal used for evaluation of equine influenza vaccines, guinea pigs were chosen as an alternative model in the present work, as they have a negligible antibody titer against equine influenza virus and are cheaper and easier to handle than foals. Five equine influenza vaccine batches were evaluated in two animal models, foals and guinea pigs, by injection of two doses/animal with 4 weeks apart using 2 mL/animal/dose and evaluation of immune responses by hemagglutination inhibition test and enzyme-linked immunosorbent assay. On the 7th week post vaccination, equine influenza antibodies titers reached maximum values of 9-10.2 and 8.7-10 hemagglutination inhibition units for foals and guinea pigs, respectively; sample/negative ratios were 0.126-0.464 and 0.128-0.445 for both animals, respectively. The use of guinea pigs as an animal model for the evaluation of equine influenza vaccines could be recommended instead of foals(AU)

La gripe equina es una enfermedad viral muy contagiosa, especialmente entre los caballos jóvenes de 1 a 5 años de edad. La vacunación se considera la mejor forma de controlar la propagación y los brotes de la enfermedad. Aunque los potros son el principal animal utilizado para la evaluación de vacunas contra la gripe equina, en el presente trabajo se eligieron cobayos como modelo alternativo, ya que tienen un título insignificante de anticuerpos contra el virus de la gripe equina y son más baratos y fáciles de manejar que los potros. Se evaluaron cinco lotes de vacunas contra la gripe equina en dos modelos animales, potros y cobayos, mediante la inyección de dos dosis/animal con 4 semanas de intervalo utilizando 2 mL/animal/dosis y la evaluación de las respuestas inmunitarias mediante la prueba de inhibición de la hemaglutinación y el ensayo inmunoenzimático. En la 7ª semana posvacunación, los títulos de anticuerpos contra la gripe equina alcanzaron valores máximos de 9-10,2 y 8,7-10 unidades de inhibición de la hemaglutinación para potros y cobayos, respectivamente; las relaciones muestras/negativos fueron de 0,126-0,464 y 0,128-0,445 para ambos animales, respectivamente. Podría recomendarse el uso de cobayos como modelo animal para la evaluación de vacunas contra la gripe equina, en lugar de potros(AU)

Assuntos

RESUMO

Since their discovery in the United States in 1963, outbreaks of infection with equine influenza virus (H3N8) have been associated with serious respiratory disease in horses worldwide. Genomic analysis suggests that equine H3 viruses are of an avian lineage, likely originating in wild birds. Equine-like internal genes have been identified in avian influenza viruses isolated from wild birds in the Southern Cone of South America. However, an equine-like H3 hemagglutinin has not been identified. We isolated 6 distinct H3 viruses from wild birds in Chile that have hemagglutinin, nucleoprotein, nonstructural protein 1, and polymerase acidic genes with high nucleotide homology to the 1963 H3N8 equine influenza virus lineage. Despite the nucleotide similarity, viruses from Chile were antigenically more closely related to avian viruses and transmitted effectively in chickens, suggesting adaptation to the avian host. These studies provide the initial demonstration that equine-like H3 hemagglutinin continues to circulate in a wild bird reservoir.

Assuntos

RESUMO

BACKGROUND: Despite the uncontrolled distribution of the Influenza A virus through wild birds, the detection of canine influenza virus and equine influenza virus in Mexico was absent until now. Recently, outbreaks of equine and canine influenza have been reported around the world; the virus spreads quickly among animals and there is potential for zoonotic transmission. METHODS: Amplification of the Influenza A virus matrix gene from necropsies, nasal and conjunctival swabs from trash service horses and pets/stray dogs was performed through RT-PCR. The seroprevalence was carried out through Sandwich enzyme-linked immunosorbent assay system using the M1 recombinant protein and polyclonal antibodies anti-M1. RESULTS: The matrix gene was amplified from 13 (19.11%) nasal swabs, two (2.94%) conjunctival swabs and five (7.35%) lung necropsies, giving a total of 20 (29.41%) positive samples in a pet dog population. A total of six (75%) positive samples of equine nasal swab were amplified. Sequence analysis showed 96-99% identity with sequences of Influenza A virus matrix gene present in H1N1, H1N2 and H3N2 subtypes. The phylogenetic analysis of the sequences revealed higher identity with matrix gene sequences detected from zoonotic isolates of subtype H1N1/2009. The detection of anti-M1 antibodies in stray dogs showed a prevalence of 123 (100%) of the sampled population, whereas in horses, 114 (92.68%) positivity was obtained. CONCLUSION: The results unveil the prevalence of Influenza A virus in the population of horses and dogs in the state of Nuevo Leon, which could indicate a possible outbreak of equine and Canine Influenza in Mexico. We suggest that the prevalence of Influenza virus in companion animals be monitored to investigate its epizootic and zoonotic potential, in addition to encouraging the regulation of vaccination in these animal species in order to improve their quality of life.

RESUMO

A new outbreak of equine Influenza A virus (IAV) was reported in Chile in January 2018, 6 years after its last report in 2012. Equine IAV was detected by rtRT-PCR, followed by virus isolation and full genome sequencing. Genetic characterization of equine IAV classified the virus within clade 1 of the Florida sublineage. Although this is the same sublineage that caused an outbreak in Chile in 2012, the virus has a high similarity to other cocirculating viruses that were recently identified in Europe and Asia. The Chilean 2018 equine influenza (EI) outbreak was caused by an H3N8 strain circulating globally that spread through horse movements.

Assuntos

RESUMO

The equine influenza virus (EIV) H3N8 subtype is responsible for all EIV outbreaks worldwide while the H7N7 subtype is less pathogenic and is considered extinct as it has not been confirmed in outbreaks since 1980. Although EIV is enzootic in Brazil, few reports describe the actual EIV antibody status in the country. The aims of this study were: - to evaluate the efficiency of different serum treatments described by the World Organisation for Animal Health (OIE) and the World Health Organization (WHO) to remove non-specific haemagglutination inhibitors for the haemagglutination inhibition (HI) assay for EIV - to evaluate the presence of EIV antibodies by HI, enzyme-linked immunosorbent assay and agar gel immunodiffusion in 83 non-vaccinated equines from São Paulo State - to evaluate a strategy to better analyse equine sera for EIV antibodies. Although there was no statistical difference among treatments, receptor-destroying enzyme treatment followed by chicken erythrocyte adsorption showed more consistent results, which corroborate the OIE and WHO recommendation to use this treatment preferentially. The HI results suggest equine H3N8 virus circulation among the animals tested from São Paulo State. The algorithm suggested here could be used to guide antibody detection against equine influenza virus in equines, improving the test specificity by aiming to avoid false positive results.

Tous les foyers de grippe équine dans le monde sont dus au sous-type H3N8 du virus. Le sous-type H7N7, moins pathogène, est considéré comme éteint, sa présence n'ayant été confirmée dans aucun des foyers enregistrés depuis 1980. Au Brésil, la grippe équine est enzootique mais la prévalence d'anticorps dans le pays est peu documentée. La présente étude avait trois objectifs : ­ évaluer l'efficacité de plusieurs traitements de sérums décrits par l'Organisation mondiale de la santé animale (OIE) et l'Organisation mondiale de la santé (OMS) sur la suppression des inhibiteurs d'hémagglutination non spécifiques, afin de pouvoir utiliser l'épreuve d'inhibition de l'hémagglutination pour la détection de la grippe équine, ­ évaluer la présence d'anticorps dirigés contre la grippe équine chez 83 chevaux non vaccinés de l'état de São Paulo en utilisant l'inhibition de l'hémagglutination, l'épreuve immuno-enzymatique (ELISA) et l'épreuve d'immunodiffusion en gélose (IDG) ; ­ évaluer une stratégie visant à améliorer les techniques sérologiques de détection des anticorps dirigés contre la grippe équine. S'il n'y a pas eu de différence statistique significative entre les traitements, celui faisant appel à l'enzyme de destruction du récepteur suivi d'une adsorption sur érythrocytes de poule a permis d'obtenir les résultats les plus cohérents, ce qui corrobore les recommandations de l'OIE et de l'OMS en faveur de ce traitement. Les résultats obtenus au moyen de l'inhibition de l'hémagglutination indiquent que le virus H3N8 est présent parmi les animaux testés de l'état de São Paulo. L'algorithme présenté par les auteurs pourrait servir de modèle pour détecter la présence d'anticorps dirigés contre le virus de la grippe équine chez les chevaux : en effet, il permet d'éviter les résultats faussement positifs, ce qui améliore la spécificité du test utilisé.

El subtipo H3N8 del virus de la gripe equina (VGE) es el agente etiológico de todos los brotes que se producen en el mundo, mientras que el subtipo H7N7, menos patogénico, se da por extinto, en la medida en que desde 1980 no se ha confirmado su intervención en brote alguno. Aunque en el Brasil el VGE es enzoótico, existen pocos trabajos que den cuenta de la situación real del país en cuanto a la presencia de anticuerpos contra el virus. Los autores describen un estudio que perseguía los siguientes objetivos: ­ evaluar la eficacia de distintos tratamientos séricos descritos por la Organización Mundial de Sanidad Animal (OIE) y la Organización Mundial de la Salud (OMS) para eliminar los inhibidores inespecíficos de la hemaglutinación con objeto de aplicar la técnica de inhibición de la hemaglutinación a la detección del VGE; ­ evaluar la presencia de anticuerpos contra el VGE por inhibición de la hemaglutinación, ensayo inmunoenzimático (ELISA) e inmunodifusión en gel de agar en 83 ejemplares equinos no vacunados del estado de São Paulo; ­ evaluar una estrategia encaminada a analizar más eficazmente sueros equinos para detectar en ellos anticuerpos anti-VGE. Aunque no se observaron diferencias estadísticamente significativas entre los tratamientos, el uso de enzimas destructores de receptores seguido de la técnica de adsorción de eritrocitos de pollo arrojó resultados más coherentes, cosa que avala la recomendación de la OIE y la OMS de privilegiar este tratamiento. Los resultados obtenidos por inhibición de la hemaglutinación parecen indicar que el virus H3N8 equino circula entre los animales analizados del estado de São Paulo. El algoritmo aquí propuesto podría servir de guía para detectar en equinos la presencia de anticuerpos contra el VGE. Puesto que apunta a evitar falsos positivos, su aplicación mejoraría la especificidad de la prueba.

Assuntos

RESUMO

Equine influenza virus (EIV) (H3N8 and H7N7) is the causative agent of equine influenza, or equine flu. The H7N7 subtype has been considered to be extinct worldwide since 1980. Affected animals have respiratory symptoms that can be worsened by secondary bacterial respiratory infection, thereby leading to great economic losses in the horse-breeding industry. In Brazil, equine influenza outbreaks were first reported in 1963 and studies on hemagglutination antibodies against viral subtypes in Brazilian horses have been conducted since then. The objective of the present review was to present the history of the emergence of EIV around the world and in Brazil and the studies that have thus far been developed on EIV in Brazilian equines...

O vírus da influenza equina (EIV) (H3N8 e H7N7) é o agente causador da influenza equina, ou gripe equina. O subtipo viral H7N7 é considerado como mundialmente extinto desde 1980. Os animais afetados têm sintomas respiratórios característicos que podem ser agravados por uma infecção respiratória bacteriana secundária causando grandes prejuízos no ramo equestre. No Brasil, os surtos da EI têm sido relatados desde 1963 e desde então vem sendo efetuados estudos sobre a presença de anticorpos hemaglutinantes contra os subtipos virais nos equídeos brasileiros. O presente artigo tem o objetivo de apresentar um histórico sobre o surgimento do EIV no mundo e no Brasil destacando os estudos conduzidos no Brasil até o momento acerca da infecção pelo EIV nos equídeos brasileiros...

Assuntos

RESUMO

Equine influenza virus (EIV) (H3N8 and H7N7) is the causative agent of equine influenza, or equine flu. The H7N7 subtype has been considered to be extinct worldwide since 1980. Affected animals have respiratory symptoms that can be worsened by secondary bacterial respiratory infection, thereby leading to great economic losses in the horse-breeding industry. In Brazil, equine influenza outbreaks were first reported in 1963 and studies on hemagglutination antibodies against viral subtypes in Brazilian horses have been conducted since then. The objective of the present review was to present the history of the emergence of EIV around the world and in Brazil and the studies that have thus far been developed on EIV in Brazilian equines.(AU)

O vírus da influenza equina (EIV) (H3N8 e H7N7) é o agente causador da influenza equina, ou gripe equina. O subtipo viral H7N7 é considerado como mundialmente extinto desde 1980. Os animais afetados têm sintomas respiratórios característicos que podem ser agravados por uma infecção respiratória bacteriana secundária causando grandes prejuízos no ramo equestre. No Brasil, os surtos da EI têm sido relatados desde 1963 e desde então vem sendo efetuados estudos sobre a presença de anticorpos hemaglutinantes contra os subtipos virais nos equídeos brasileiros. O presente artigo tem o objetivo de apresentar um histórico sobre o surgimento do EIV no mundo e no Brasil destacando os estudos conduzidos no Brasil até o momento acerca da infecção pelo EIV nos equídeos brasileiros.(AU)

Assuntos

RESUMO

Equine Influenza: evaluation of the humoral immune response through the hemagglutination inhibition and single radial haemolysis, in horses vaccinated with commercial and experimental vaccines. From 4 equine groups, the antibody protection levels against influenza were evaluted through the hemagglutination inhibition and single radial haemolysis. One group of these animals received immunization from 2 doses of influenza vaccine, of experimental preparation, at the Butantan Institute, São Paulo, Brasil (IB). Two other horse groups, regularly vaccinated received the annual booster dose from both commercial and experimental vaccines (IB). A control group remained without vaccination. Differences were observed among the antibody level medians of the serum samples harvested prior and post immunization of those vaccinated animals. No evident differences were detected among the antibody level medians from animals that received annual booster doses, due to the persistence of the protective antibody level, 12 months after the regular immunization. In the control group, the animals showed low antibody levels, for both serum samples. In fact these results suggested the good serologic response of both vaccines, the commercial and the experimental, tested preparations.

Foram avaliadas, através de testes de inibição da hemaglutinação (Hl) e da hemólise radial simples (HRS),as respostas de anticorpos contra influenza em 4 lotes de eqüinos adultos. O grupo do lote 01 recebeu a imunizaçãocom 2 doses de vacina contra influenza, preparada experimentalmente no Instituto Butantan. Noslotes 02 e 03, regularmente imunizados contra a influenza, foram administradas doses de reforço anual coma vacina comercial e com a vacina experimental, respectivamente. O lote 04 foi o grupo controle da avaliação.Os resultados dos testes demonstraram que as médias de títulos de HRS e IH do lote 01 apresentaram diferenças ao nível de p 0,001, com significante aumento das médias de títulos detectados nos soros após a 2- imunização. Não foram observadas diferenças significantes entre as médias de títulos de anticorpos em soros obtidos antes e após a dose de reforço anual dos eqüinos dos lotes 02 e 03, atribuindo-se a persistênciade nível de anticorpos protetores mantida após 1 ano da imunização  regular com vacina comercial. A conversão sorológica dos eqüinos do lote 01, à persistência dos títulos de anticorpos nos eqüinos dos lotes 02 e 03 e, ainda, os baixos títulos de anticorpos verificados nos eqüinos não vacinados do lote 04 comprovam o resultado da resposta sorológica das duas vacinas, a experimental e a comercial, avaliadas neste trabalho.